North Sea oil hit record highs today as Iran war day 19 kept hold over the Strait of Hormuz. FT reported Washington-Tehran ceasefire agreement failed to stem the global energy crunch. Investors warned the conflict will leave a long-term scar on Wall Street.
Commodity prices and bond yields are unlikely to return to pre-conflict levels quickly. BP agreed to acquire 60% operator interest in three offshore exploration blocks in Namibia. The $105B energy giant positioned for African opportunities as Middle East supply stayed constrained.
GSK reported mocertatug rezetecan achieved 62% response rate in platinum-resistant ovarian cancer. The 67% response in endometrial cancer marked major Phase 1 BEHOLD-1 trial progress. DHR Danaher launched a 20-minute bacterial versus viral infection differentiation assay through Beckman Coulter.
PFE Pfizer extended its IBD digital application licensing agreement with Trellus Health. The partnerships highlighted pharma's resilience-driven platform value.
SoftBank, NEC, Sony and Honda formed a new company to target AI rollout. The consortium aims to close gaps with US and China in artificial intelligence deployment. Japan's tech giants coordinated resources as global competition intensified.
MTB M&T Bank saw Wall Street forecasters revamp expectations ahead of Q1 earnings. The $15B regional lender faced scrutiny on credit quality. TSLA Tesla barred customers from selling Model S and X Signature Edition within one year of purchase showing tighter secondary market controls.
European markets opened lower today as Iran peace hopes faded. Travel stocks plunged on extended conflict expectations. Asia-Pacific markets traded mixed as investors assessed Trump's hardened Iran rhetoric.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
